Xalkori 250 mg (Crizotinib 250 mg per capsule) by Pfizer.
Indications: ALK-positive and ROS1-positive advanced non-small cell lung cancer.
Administration: Oral: 250 mg twice daily.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Pfizer |
| Active ingredient | Crizotinib 250 mg per capsule — ALK/ROS1 inhibitor. |
| Strength & pack | 60 hard capsules. |
| Form | Hard capsules |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |